Clinical trial
Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke: a Randomised, Double-blind, Placebo-controlled Trial
NCT01525290 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke: a Randomised, Double-blind, Placebo-controlled Trial
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- October 31, 2018
- Enrollment
- 501 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.